Top Markets
Coin of the day
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Classificação em ações #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Preço da ação
$1.85
Última sincronização: 2024-08-19
Valor de mercado
$3.96M
Variação (1 dia)
2.78%
Variação (1 ano)
0.00%
País
US
Negociar MyMD Pharmaceuticals, Inc. (MYMD)

Categoria

Histórico de preços das ações de MyMD Pharmaceuticals, Inc. (MYMD)
Preço de fecho mais alto: $1.83 em 2024-08-01

Preço de fecho mais baixo: $120.01K em 2014-01-01
Histórico de preços das ações da MyMD Pharmaceuticals, Inc. de 2014 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -76.01%
2023 -82.01%
2022 -78.21%
2021 60.05%
2020 -42.41%
2019 -86.46%
2018 -78.63%
2017 -81.85%
2016 23.71%
2015 -54.94%
2014 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE